After its top vaccine official left the Food and Drug Administration (FDA), the agency announced Tuesday that it has named his replacement.
In an April 1 statement on X, the FDA said Scott Steele would be the acting head of the Center for Biologics Evaluation and Research (CBER), which Peter Marks once led.